Travere Therapeutics Inc. (TVTX)

AI Score

Unlock

15.26

-1.30 (-7.85%)

At close: Apr 04, 2025, 10:53 AM

Travere Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Feb 29, 2012	Feb 28, 2011	Feb 28, 2010	Feb 28, 2009
Cash & Equivalents	58.53M	58.18M	61.69M	165.75M	84.77M	62.44M	102.87M	99.39M	41M	37.8M	18.2M	6M	11.39K	3.91K	3.96K	n/a	4.77K
Short-Term Investments	312.17M	508.68M	388.56M	387.13M	276.82M	336.09M	368.67M	201.24M	214.87M	191.8M	9.56M	132.99K	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	15M	-16.81M	-6.42M	21.25M	-140.81M	-2.6B	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	53.82M	42.16M	11.06M	11.07M	33.49M	14.71M	-25M	5.56M	7.36M	2M	1.93M	40K	137.55K	n/a	n/a	n/a	n/a
Receivables	27.12M	21.18M	16.65M	15.91M	33.07M	18.05M	14.49M	13.87M	65.36M	59.31M	7.96M	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	6.2M	9.41M	6.92M	7.31M	7.61M	6.08M	5.62M	5.35M	2.83M	2.54M	800.51K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	12.69M	19.34M	15.02M	247K	n/a	6.41M	2.31M	5.95M	4.83M	2.38M	813.36K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	416.7M	616.77M	486.44M	582.83M	410.41M	429.06M	495.68M	325.81M	332.35M	301.93M	37.33M	7.5M	33.22K	3.91K	3.96K	n/a	4.77K
Property-Plant & Equipment	19.63M	25.54M	30.05M	34.3M	9.42M	2.89M	3.15M	3.23M	2.59M	428K	670.8K	127.43K	23.79K	n/a	n/a	n/a	n/a
Goodwill & Intangibles	103.97M	104.44M	145.04M	148.44M	154.13M	158.14M	187.63M	185.75M	182.98M	162.47M	95.2M	12.59M	2.2M	n/a	n/a	n/a	n/a
Total Long-Term Assets	177.42M	172.14M	186.15M	193.81M	197.03M	175.74M	213.48M	194.54M	192.93M	210.47M	98.14M	13M	2.36M	n/a	n/a	n/a	n/a
Total Assets	594.13M	788.91M	672.59M	776.63M	607.44M	604.8M	709.16M	520.35M	525.28M	512.4M	135.47M	20.5M	2.39M	3.91K	3.96K	n/a	4.77K
Account Payables	23.53M	41.67M	17.29M	15.14M	12.13M	26.61M	6.95M	18.94M	7.52M	7.64M	7.12M	3.55M	1.02M	750.00	750.00	n/a	750.00
Deferred Revenue	2.81M	7.1M	11.98M	16.27M	-357K	-2.61M	49.7M	n/a	n/a	n/a	28.88M	n/a	2.49M	n/a	n/a	n/a	n/a
Short-Term Debt	74.08M	n/a	4.43M	3.91M	n/a	n/a	22.46M	n/a	n/a	n/a	40.49M	n/a	884.76K	25K	25K	n/a	4.17K
Other Current Liabilities	100.32M	94.32M	68.76M	58.86M	62.26M	54.79M	64.76M	58.98M	68.3M	72.2M	40.21M	29.27M	2.87M	n/a	n/a	n/a	28.94K
Total Current Liabilities	200.75M	177.91M	142.16M	124.09M	92.66M	95.45M	104.62M	85.67M	83.26M	85.8M	107.54M	35.21M	5.8M	66.99K	64.21K	n/a	33.86K
Long-Term Debt	327.5M	377.26M	403.06M	226.58M	215.34M	204.86M	195.09M	45.08M	44.42M	43.77M	43.29M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.8M	8.48M	46.08M	71.98M	59.89M	83.29M	91.19M	96.47M	83.41M	81.55M	21.9M	1M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	334.3M	410.19M	487.57M	350.43M	303.57M	288.15M	286.29M	141.54M	134.25M	126.63M	65.18M	3.6M	1.91M	n/a	25.75K	n/a	n/a
Total Liabilities	535.05M	588.1M	629.73M	474.52M	396.23M	383.6M	390.91M	227.21M	217.51M	212.43M	172.72M	38.81M	5.8M	66.99K	64.21K	n/a	33.86K
Total Debt	401.58M	404.78M	407.49M	261.99M	215.34M	204.86M	217.55M	45.08M	44.42M	43.9M	83.77M	n/a	884.76K	25K	25K	n/a	4.17K
Common Stock	9K	7K	6K	6K	5K	4K	4K	4K	4K	4K	2.64K	1.85K	895.00	11.00	11.00	n/a	n/a
Retained Earnings	-1.45B	-1.13B	-1.01B	-765.97M	-585.88M	-416.44M	-270.02M	-177.66M	-113.06M	-65.15M	-179.17M	-67.44M	-33.61M	-136.08K	-121.26K	n/a	-70.26K
Comprehensive Income	-80K	-1.46M	-2.91M	-562K	-902K	726K	-1.53M	-1.01M	-490K	-682K	4.29M	-109.99K	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	59.08M	200.81M	42.85M	302.11M	211.21M	221.2M	318.25M	293.13M	307.77M	299.97M	-37.25M	-18.31M	-3.41M	-63.08K	-60.26K	n/a	1.00
Total Investments	312.17M	508.68M	388.56M	387.13M	276.82M	336.09M	383.67M	201.24M	214.87M	191.8M	9.56M	132.99K	n/a	n/a	n/a	n/a	n/a